Philip T. Leese - Concepedia

Author

Philip T. Leese

Also Known As

James Hainer, P LEESE, P T Leese, P. Leese, P. T. Leese, P.T. Leese, PHILIP LEESE, PHILIP T. LEESE, Philip Leese, Philip T Leese

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

IQVIA (United States)Amgen (United States)IQVIA (United Kingdom)Quincy Medical Center Abbott Fund

About

Philip T. Leese is an author at IQVIA (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.1K
2	Health Sciences	4	4	180
3	Engineering	2	2	209
4	Public Health	1	1	41
5	Anesthesia	1	1	79

Philip T. Leese

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women Pirow Bekker, Donna Holloway, Amy S Rasmussen, Journal of Bone and Mineral Research	2004	761
The Effect of a Single Dose of Osteoprotegerin in Postmenopausal Women Pirow Bekker, Donna Holloway, Arline Nakanishi, Journal of Bone and Mineral Research	2001	490
Effects of Celecoxib, a Novel Cyclooxygenase‐2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial Philip T. Leese, Richard C. Hubbard, Aziz Karim, The Journal of Clinical Pharmacology	2000	373
Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies David Planchard, Kathryn H. Brown, Dong‐Wan Kim, Cancer Chemotherapy and Pharmacology Therapeutic Drug MonitoringHealthy VolunteersPharmacologyAsian Clinical PharmacokineticsPharmacological Issue	2016	142
Hepatobiliary MR imaging: first human experience with MnDPDP. Kelvin O. Lim, David D. Stark, Philip T. Leese, Radiology Hepatobiliary Mr ImagingImaging AnatomyTwelve Healthy SubjectsHepatologyMedical Imaging	1991	130
Pharmacokinetics of a Once-Daily Oral Dose of Moxifloxacin (Bay 12-8039), a New Enantiomerically Pure 8-Methoxy Quinolone John T. Sullivan, Marilyn Woodruff, John Lettieri, Antimicrobial Agents and Chemotherapy Drug SafetyBay 12-8039Therapeutic Drug MonitoringBlood ChemistryMedicine	1999	117
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women Pirow Bekker, Donna Holloway, Amy S Rasmussen, Journal of Bone and Mineral Research Single-dose Placebo-controlled StudyAmg 162ImmunologyGynecologyPharmacotherapy	2005	97
Valdecoxib does not impair platelet function Philip T. Leese, Sheela Talwalker, Jeffrey D. Kent, The American Journal of Emergency Medicine ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletMedicine	2002	90
A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement Agent MICHELLE VAN WAGONER, Melissa O'toole, Dilip Worah, Investigative Radiology Ascending-dose StudyEngineeringImaging AgentPharmacotherapyMagnetic Resonance Imaging	1991	79
Phase 1 Study of Two Merozoite Surface Protein 1 (MSP142) Vaccines for Plasmodium falciparum Malaria Elissa Malkin, Carole A. Long, Anthony W. Stowers, PLoS Clinical Trials	2007	78

Page 1